New findings from more than 20,000 patients across three major NIH studies suggest that elevated Lipoprotein(a) [Lp(a)] may contribute to cardiovascular risk that remains even after standard treatment. The results indicate that people with high Lp(a) may benefit from more aggressive efforts to reduce other heart disease risk factors.
The late-breaking findings were presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2026 Scientif...

1 week ago
35







English (US) ·